Literature DB >> 6863363

The effects of intravenous regional guanethidine and reserpine. A controlled study.

C W McKain, B J Urban, J L Goldner.   

Abstract

We investigated the effects of intravenous regional injection of guanethidine and reserpine in a prospective, randomized, double-blind study of seven volunteers. The sympatholytic activities of these drugs were assessed separately for cholinergic and adrenergic function. Cold challenge was employed to magnify the effect on digital temperatures and alterations in pulse-volume. Only guanethidine significantly increased temperature (p less than 0.025) after cold challenge, this effect lasting for three days. No anticholinergic effect was found. Intravenous regional guanethidine may be useful in the treatment of vasospastic disorders and as prophylaxis for surgically treated patients in whom this complication may be expected to occur.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863363

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

1.  Treatment of severe, recalcitrant reflex sympathetic dystrophy: assessment of efficacy and safety of the second generation bisphosphonate pamidronate.

Authors:  B Cortet; R M Flipo; P Coquerelle; B Duquesnoy; B Delcambre
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 2.980

2.  Regional intravenous guanethidine blocks in algodystrophy.

Authors:  F Eulry; D Lechevalier; B Pats; C Alliaume; P Crozes; P Vasseur; G Coutant; D Felten; S Pattin
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

Review 3.  Complex regional pain syndrome: a review of evidence-supported treatment options.

Authors:  E Daniela Hord; Anne Louise Oaklander
Journal:  Curr Pain Headache Rep       Date:  2003-06

4.  [Drug therapy in complex regional pain syndrome type I].

Authors:  R Von Eisenhart-Rothe; M Rittmeister
Journal:  Orthopade       Date:  2004-07       Impact factor: 1.087

5.  Intravenous regional anesthesia with ketorolac-lidocaine for the management of sympathetically-mediated pain.

Authors:  N R Connelly; S Reuben; S J Brull
Journal:  Yale J Biol Med       Date:  1995 May-Aug
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.